[{"address1": "1560 Trapelo Road", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "781 786 8230", "fax": "781 786 8866", "website": "https://www.dyne-tx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 191, "companyOfficers": [{"maxAge": 1, "name": "Mr. John G. Cox M.B.A.", "age": 61, "title": "CEO, President & Director", "yearBorn": 1963, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Romesh  Subramanian Ph.D.", "age": 59, "title": "Co-Founder & Advisor", "yearBorn": 1965, "fiscalYear": 2020, "totalPay": 565170, "exercisedValue": 0, "unexercisedValue": 284933}, {"maxAge": 1, "name": "Mr. Richard William Scalzo M.B.A.", "age": 37, "title": "Senior VP and Head of Finance & Administration", "yearBorn": 1987, "fiscalYear": 2020, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Oxana  Beskrovnaya Ph.D.", "age": 63, "title": "Chief Scientific Officer", "yearBorn": 1961, "fiscalYear": 2020, "totalPay": 631076, "exercisedValue": 0, "unexercisedValue": 1167727}, {"maxAge": 1, "name": "Mr. Daniel  Wilson", "age": 52, "title": "Senior VP & Head of Legal", "yearBorn": 1972, "fiscalYear": 2020, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lucia  Celona", "age": 58, "title": "Chief Human Resource Officer", "yearBorn": 1966, "fiscalYear": 2020, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Debra  Feldman", "age": 53, "title": "Chief Regulatory Affairs Officer", "yearBorn": 1971, "fiscalYear": 2020, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ashish  Dugar M.B.A., Ph.D.", "title": "Chief Medical Affairs Officer", "fiscalYear": 2020, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Johanna  Friedl-Naderer", "age": 56, "title": "Chief Commercial Officer", "yearBorn": 1968, "fiscalYear": 2020, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Douglas  Kerr M.B.A., M.D., Ph.D.", "age": 57, "title": "Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2020, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1609372800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 11.8, "open": 11.8, "dayLow": 11.245, "dayHigh": 11.995, "regularMarketPreviousClose": 11.8, "regularMarketOpen": 11.8, "regularMarketDayLow": 11.245, "regularMarketDayHigh": 11.995, "payoutRatio": 0.0, "beta": 1.111, "forwardPE": -3.6234176, "volume": 1111023, "regularMarketVolume": 1111023, "averageVolume": 2102940, "averageVolume10days": 1947210, "averageDailyVolume10Day": 1947210, "bid": 8.56, "ask": 14.46, "bidSize": 1, "askSize": 2, "marketCap": 1295235456, "fiftyTwoWeekLow": 10.72, "fiftyTwoWeekHigh": 47.45, "fiftyDayAverage": 13.2888, "twoHundredDayAverage": 28.62625, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 676959552, "profitMargins": 0.0, "floatShares": 97275317, "sharesOutstanding": 113121000, "sharesShort": 12383217, "sharesShortPriorMonth": 10895395, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.1095, "heldPercentInsiders": 0.0068800002, "heldPercentInstitutions": 1.0083799, "shortRatio": 7.74, "shortPercentOfFloat": 0.1276, "impliedSharesOutstanding": 113121000, "bookValue": 6.156, "priceToBook": 1.8599739, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -317417984, "trailingEps": -3.37, "forwardEps": -3.16, "enterpriseToEbitda": -1.978, "52WeekChange": -0.5910714, "SandP52WeekChange": 0.06429911, "quoteType": "EQUITY", "currentPrice": 11.45, "targetHighPrice": 66.0, "targetLowPrice": 17.0, "targetMeanPrice": 48.21429, "targetMedianPrice": 50.0, "recommendationMean": 1.57143, "recommendationKey": "buy", "numberOfAnalystOpinions": 14, "totalCash": 642268032, "totalCashPerShare": 5.678, "ebitda": -342212992, "totalDebt": 23988000, "quickRatio": 15.199, "currentRatio": 15.601, "debtToEquity": 3.809, "returnOnAssets": -0.50198, "returnOnEquity": -0.88034, "freeCashflow": -189470752, "operatingCashflow": -292368992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "DYN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Dyne Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1743194037, "regularMarketTime": 1743192000, "exchange": "NMS", "messageBoardId": "finmb_608699906", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "regularMarketChangePercent": -2.9661047, "regularMarketPrice": 11.45, "postMarketChangePercent": 0.0, "postMarketPrice": 11.45, "postMarketChange": 0.0, "regularMarketChange": -0.35000038, "regularMarketDayRange": "11.245 - 11.995", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2102940, "fiftyTwoWeekLowChange": 0.72999954, "fiftyTwoWeekLowChangePercent": 0.06809697, "fiftyTwoWeekRange": "10.72 - 47.45", "fiftyTwoWeekHighChange": -36.0, "fiftyTwoWeekHighChangePercent": -0.75869334, "fiftyTwoWeekChangePercent": -59.107143, "longName": "Dyne Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1600349400000, "earningsTimestamp": 1740659400, "earningsTimestampStart": 1746043200, "earningsTimestampEnd": 1746475200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.37, "epsForward": -3.16, "epsCurrentYear": -3.48343, "priceEpsCurrentYear": -3.2869902, "fiftyDayAverageChange": -1.8388004, "fiftyDayAverageChangePercent": -0.1383722, "twoHundredDayAverageChange": -17.17625, "twoHundredDayAverageChangePercent": -0.6000175, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-09-17", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "displayName": "Dyne Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-29"}]